why choose us

Clinical Trials Search

Showing 18,350 of 132,963 result(s)
An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Status: Active, not recruiting

Condition: An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-rel

Interventions: Interventional

Date: 2022-11-11

Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer

Status: Completed

Condition: Locally Advanced Rectal Carcinoma

Interventions: Interventional

Date: 2022-11-11

The Detection of Heat Stress by Assessing Individual Body Responses to Heat (Heat Strain) in Young and Healthy Non-athlete Participants

Status: Completed

Condition: Heat Stress

Interventions: Other: Elevated ambient heat
Temporary exposure to increased ambient temperature +10°C (the effect of the intervention is fully and spontaneously

Date: 2022-11-11

MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

Status: Completed

Condition: Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Interventions: Interventional

Date: 2022-11-11

A Study of Effect of LY3556050 on Metformin in Healthy Participants

Status: Completed

Condition: Healthy

Interventions: Interventional

Date: 2022-11-11

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

Status: Completed

Condition: Renal Insufficiency

Interventions: INCB054707 75 mg will be administered orally

Date: 2022-11-11

Neighborhood-based Physical and Social Activity for Older Black Caregivers and People Living With Dementia

Status: Completed

Condition: Caregiver Burden

Interventions: Technology-enabled neighborhood walking 3x;week for 16 weeks with conversational reminiscence

Date: 2022-11-11

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

Status: Completed

Condition: Graft-versus-host Disease

Interventions: 25 mg;kg by IV on Days +3 and +4.

Date: 2022-11-11

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Status: Completed

Condition: BPH With Urinary Obstruction

Interventions: 20mg of IV furosemide injection during the morcellation phase of HoLEP

Date: 2022-11-11